Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs

Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs

Yuren Wang,1 Jason Wallach,2 Stephanie Duane,1 Yuan Wang,1 Jianghong Wu,1 Jeffrey Wang,1 Adeboye Adejare,2 Haiching Ma1 1Reaction Biology Corp., Malvern, 2Department of Pharmaceutical Sciences, Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, PA, USA Abstract: Histone de...

Full description

Bibliographic Details
Main Authors: Wang Y, Wallach J, Duane S, Wu J, Wang J, Adejare A, Ma H
Format: Article
Language:English
Published: Dove Medical Press 2017-05-01
Series:Drug Design, Development and Therapy
Subjects:
HDAC
inhibitor
Ebselen
Drug
Online Access:https://www.dovepress.com/developing-selective-histone-deacetylases-hdacs-inhibitors-through-ebs-peer-reviewed-article-DDDT

Internet

https://www.dovepress.com/developing-selective-histone-deacetylases-hdacs-inhibitors-through-ebs-peer-reviewed-article-DDDT

Similar Items